(Q51089882)

English

The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease.

scientific article published on 20 May 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/24798049

The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. (English)

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/24798049

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-invasive diagnostics

1 reference

based on heuristic

inferred from title

Salvatore Petta

1

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/24798049

8

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/24798049

6

object named as

Daniela Cabibi

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/24798049

Elisabetta Bugianesi

3

object named as

Elisabetta Bugianesi

1 reference

Europe PubMed Central

29 March 2018

Calogero Cammà

5

object named as

Calogero Cammà

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/24798049

author name string

Ester Vanni

2

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/24798049

Vito Di Marco

4

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/24798049

Lavinia Mezzabotta

7

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/24798049

publication date

20 May 2014

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/24798049

Liver International

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/24798049

35

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/24798049

5

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/24798049

1566-1573

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/24798049

Non-alcoholic fatty liver disease pathogenesis: the present and the future

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance?

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Non invasive indexes for the assessment of patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Noninvasive evaluation of NAFLD.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Comparison of blood tests for liver fibrosis specific or not to NAFLD.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Performance of transient elastography for the staging of liver fibrosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12584

21 January 2018

Identifiers

10.1111/LIV.12584

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/24798049

1 reference

Europe PubMed Central

29 March 2018

http://europepmc.org/abstract/MED/24798049

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51089882&oldid=2035250529"